Back to search
FDAFDA · Food and drugs·Recall number D-0687-2018

Ibuprofen Tablets USP 400 mg, a) 100 tablet (NDC 49483-602-01) and b) 500 tablet (NDC 49483-602-50) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, USA, Manufactured by: Marksans Pharma, Ltd., Plot No. L-82, L-83 Verna indl. Estate Verna, Goa-403 722, India

Published May 2, 2018 · Recall initiated: January 11, 2018

Summary

FDA records drug Class II recall D-0687-2018, published May 2, 2018 and initiated January 11, 2018. Recalling firm: Time-Cap Laboratories, Inc.; Status: Terminated; Reported quantity: N/A; Lot: a) M104C, exp 9/18, L016C, H092C, and H093C, exp 9/18 b) C128C, C129C, C130C, C132C, exp 3/18, HK6011, exp 7/18, L016C and H092C, exp 9/18,. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

What to do

Voluntary: Firm initiated · Letter

Get an email if IBUPROFEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
IBUPROFEN
Manufacturer
Time-Cap Laboratories, Inc.
Distributor
Nationwide.
UPC
0349483604504
Lot
a) M104C, exp 9/18, L016C, H092C, and H093C, exp 9/18 b) C128C, C129C, C130C, C132C, exp 3/18, HK6011, exp 7/18, L016C and H092C, exp 9/18,
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ibuprofen Tablets USP 400 mg, a) 100 tablet (NDC 49483-602-01) and b) 500 tablet (NDC 49483-602-50) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, USA, Manufactured by: Marksans Pharma, Ltd., Plot No. L-82, L-83 Verna indl. Estate Verna, Goa-403 722, India recalled?

Yes. FDA published recall D-0687-2018 on May 2, 2018. Reported hazard: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: IBUPROFEN. UPC: 0349483604504.